The Kirov branch of AVVA RUS received the FDA GMP certificate
Pharmaceutical company JSC "AVVA RUS", which is included in the list of systemically important enterprises of the Kirov region, underwent an audit at the beginning of 2020 by the drug regulatory authorities of Saudi Arabia (Saudi FDA) for GMP compliance in the Middle Eastern region. Recently, it received official documentation confirming the successful completion of the inspection, which will be certified by the corresponding certificate.
It is worth noting that AVVA RUS, which operates in accordance with Russian GMP standards and ISO 9001, received a similar European GMP EU certificate in 2018.
Thus, AVVA RUS is one of the few Russian companies to have passed the GMP certification procedure by representatives of the Saudi FDA and has once again confirmed the highest quality of its manufactured products and their recognition at the international level.
Download link for the certificate
Download link for the certificate translation
Preparations of our production:
On prescription:
Azithromycin Ecomed® tablets 500 mg , Amoxicillin Ekobol® tablets 250 mg , Amoxicillin Ekobol® tablets 500 mg , Amoxicillin tablets 250 mg , Amoxicillin tablets 500 mg , Amiodarone tablets 200 mg , Verapamil tablets 80 mg
Over the counter:
Media Contacts
Subscribe to get the latest news and articles
